Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer

Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer

Abstract We prospectively evaluated the utility of ESR1 and PIK3CA mutation analysis with cell-free DNA (cfDNA) using droplet digital PCR (ddPCR) for the efficacy of endocrine therapy (ET) in hormone receptive positive (HR+) metastatic breast cancer (MBC) patients. CfDNA was analyzed just before the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sung Hoon Sim, Han Na Yang, Su Yeon Jeon, Keun Seok Lee, In Hae Park
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f8a712deeda54440806a3089f6dc5920
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares